Press
New research led by MIT Sloan School of Management’s Dimitris Bertsimas shows how a novel, data-driven algorithm can improve the prognosis for type 2 diabetes
The algorithm is applicable to other diseases, including cancer and Alzheimer's disease
Dec 5, 2016